Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Elucent Medical in the transaction. Elucent Medical, a pioneering medical technology company, announced it raised $42.5 million in...
Elucent Medical’s $42.5 Million Series C Financing Round
Moonwalk Biosciences’ $57 Million Series A Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Moonwalk Biosciences in the transaction. Moonwalk Biosciences announced it had completed the Series A and Seed financings totaling $57 million....
Pano AI’s $20 Million Series A Financing
Gunderson Dettmer represented Pano AI on the deal. Pano AI announced its $20 million Series A financing led by Initialized Capital Management. Pano AI is a developer...
Gordian Software’s $25 Million Series A Financing
Gunderson Dettmer represented Gordian Software on the deal. Gordian Software announced its $25 million Series A financing co-led by Accomplice and Vinyl with participation from Kinnevik,...
Backblaze’s IPO
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Backblaze on the deal. White & Case advised Oppenheimer & Co. Backblaze, a provider of cloud storage and...
TuSimple’s $1.35 Billion Initial Public Offering
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised TuSimple on the deal, while Davis Polk advised the representatives of the several underwriters. TuSimple, a San...
Tarsus Pharmaceuticals’ Strategic Partnership with LianBio
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Tarsus Pharmaceuticals, Inc. on the deal. Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company, and...